D. Shin

Molecular Biology · Nature reviews. Drug discovery · 2006–2008

A researcher in the Science corpus: 6 papers; trusts 2 researchers and is trusted by 6 researchers here, as inferred from the citation graph.

Subfields

Whom D. Shin trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. R. Duncan

Who trusts D. Shin overall

  1. Stephanie D. Steichen
  2. J. D. Rocca

Papers from D. Shin's perspective

Ordered by how strongly the researchers D. Shin trusts endorse each paper. Same corpus, a different order for every researcher.

  1. The dawning era of polymer therapeutics (Nature reviews. Drug discovery)
  2. Multidrug resistance in cancer: role of ATP–dependent transporters (Nature Reviews. Cancer)
  3. Mechanisms of cancer drug resistance. (Annual Review of Medicine)
  4. Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel. (Clinical Cancer Research)
  5. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. (Advances in Enzyme Regulation)
  6. Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer. (Journal of Clinical Oncology)
  7. Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers. (Journal of the National Cancer Institute)
  8. Quantum dots as luminescent probes in biological systems
  9. Effect of pegylation on pharmaceuticals (Nature reviews. Drug discovery)
  10. Toxicity and tissue distribution of magnetic nanoparticles in mice. (Toxicological Sciences)

Their papers